Posts Tagged ‘generex-biotechnology’
DALLAS — MicroStockProfit.com announces an investment report featuring Generex Biotechnology Corp. .
Antigen Express granted patent for AE37 immunotherapeutic vaccine: Generex Biotechnology
14 Jul 2010Generex Biotechnology Corporation today announced that its wholly-owned subsidiary, Antigen Express, Inc., has been granted a United States patent on AE37, its lead immunotherapeutic vaccine. While Antigen Express has a strong intellectual property foundation on all Ii-Key technology, this is the first “composition of matter” patent to be issued relating to one of their development products.
WORCESTER, Mass. — Generex Biotechnology Corporation today announced its participation in the Gateway to China Business Round Table Conference held in Orlando, Florida June 28 & 29.
Generex Biotechnology to Participate in World’s Largest and Most Prestigious Diabetes Meeting
22 Jun 2010WORCESTER, Mass. — Generex Biotechnology Corporation today announced its participation as an exhibitor during the 70th Scientific Sessions organized by the American Diabetes Association .
Generex Biotechnology to Participate in American Society of Clinical Oncology Annual Meeting in Chicago
26 May 2010WORCESTER, Mass. — Generex Biotechnology Corporation today announced that its wholly owned subsidiary, Antigen Express, Inc. , will be participating in the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois June 4 through June 8 at McCormick Place.
Dubai to host biotechnology forum
20 May 2010Dubai, May 20: Scores of experts from the Middle East will take part in a biotechnology forum to be held in Dubai May 24.
Generex Biotechnology (GNBT) just announced a few minutes ago that results from its first Phase I study of its lead immunotherapeutic agent AE37, in patients with prostate cancer, have been published in the journal Clinical Cancer Research.
DALLAS — MicroStockProfit.com announces an investment report featuring Generex Biotechnology Corp. .
Generex Biotechnology Corporation announced today publication of results from the first Phase I study of its lead immunotherapeutic agent AE37 in patients with prostate cancer. At the end of 2009, the Company announced positive interim results from a Phase II trial being conducted with AE37 in patients with breast cancer
Generex Biotechnology Corporation announced today publication of results from the first Phase I study of its lead immunotherapeutic agent AE37 in patients with prostate cancer. At the end of 2009, the Company announced positive interim results from a Phase II trial being conducted with AE37 in patients with breast cancer. The compound is being developed by its wholly-owned subsidiary, Antigen …
About Biolexis
Biolexis is a premiere online resource for life sciences professionals, investors and entrepreneurs. The site offers personalized information biotechnology news and other biotechnology resources. Information is further organized by industry sector, therapeutic areas, technology focus, service orientation, and location. With Biolexis, you can: access over 5,000 biotechnology news strories and biotechnology articles. Search biotech company information, biotech news, biotech articles and biotech related press releases.
Biotech
Categories
- Biotechnology News (4129)
Archives
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- November 2008
- October 2008
- August 2008
- July 2008
- June 2008
- April 2008
- February 2008
- January 2008
- December 2007
- August 2007
- July 2007
- June 2007
- April 2007
- February 2007
- December 2006
- September 2006
- August 2006
- Impact Of Demonstration Of Vermy Composting For The Benefit Of Sc …
- » Generex Biotechnology Corp. is Today's Focus Stock on …
- Biotech Grants – Biotechnology Funding – Biotechnology Grants …
- Regenerating damaged tissues: Bioscaffolds promote growth of joints in rabbits
- The Basics of Modern Biotechnology | The World of Snark
- Generex Pipeline Review by R J Steffens: Previewing Generex …
- Biotechnology in India | Bio Technology
- Molecular Biology as a career | Bio Technology
- Generex Biotechnology Corp. is Today’s Focus Stock on MicroStockProfit.com
- new job search» Blog Archive » The Future of Biotechnology Jobs in …
